Colorectal Cancer, An Issue of Hematology/Oncology Clinics, E-Book

Colorectal Cancer, An Issue of Hematology/Oncology Clinics, E-Book

This issue of Hematology/Oncology Clinics of North America, devoted to Colorectal Cancer, is edited by Dr. Leonard B. Saltz. Articles in this issue include: Diet and Lifestyle Influences on Colorectal Cancer; Diagnosis and Management of Germline and Somatic Mutations in Mismatch Repair-deficient Colorectal Cancer; Adjuvant Chemotherapy in Stage II, III, and Resected Stage IV Colon […]

Circulating Tumor Cells in Patients Undergoing Surgery for Hepatic Metastases from Colorectal Cancer (Clinical Report)

Circulating Tumor Cells in Patients Undergoing Surgery for Hepatic Metastases from Colorectal Cancer (Clinical Report)

The liver is often the only site of metastatic disease in patients with colorectal cancer, and such patients are considered for local therapies such as liver resection or tumor ablation. The 5-year survival rate for surgically treated patients is approximately 30% (1). Disease recurrence may be related to intraoperative factors such as the shedding of […]

Hepatic Artery Chemotherapy in the Management of Colorectal Metastases (Clinical Report)

Hepatic Artery Chemotherapy in the Management of Colorectal Metastases (Clinical Report)

Each year in the USA, approximately 200,000 people are diagnosed with primary colorectal cancer; 75,000 patients with colorectal cancer do not survive, and half of those who survive develop tumor recurrence. Sixty percent of recurrences are found in the liver, 10% of which will be resectable. Patients at high risk of developing metastases from colorectal […]

Patterns of Care in Medical Oncology: Current Practice Patterns of General Medical Oncologists — Metastatic Colorectal Cancer Module

Patterns of Care in Medical Oncology: Current Practice Patterns of General Medical Oncologists — Metastatic Colorectal Cancer Module

Patterns of Care in Metastatic Colorectal Cancer is a unique continuing medical education activity that presents findings from a national survey of 101 general oncologists and the video recorded perspectives of clinical investigators Drs Johanna C Bendell and Alan P Venook on their approaches to key management challenges in metastatic colorectal cancer.

Number of Lymph Nodes Examined and Associated Clinicopathologic Factors in Colorectal Carcinoma (Report)

Number of Lymph Nodes Examined and Associated Clinicopathologic Factors in Colorectal Carcinoma (Report)

Colorectal carcinoma is the second most common cause of cancer deaths in the United States. (1) The most important prognostic factor in colorectal carcinoma is the nodal status at the time of surgical treatment. The 5-year survival rate for stages I and II colorectal carcinomas is greater than 75%. With nodal metastasis, the 5-year survival […]

Colorectal Cancer, An Issue of Hematology/Oncology Clinics

Colorectal Cancer, An Issue of Hematology/Oncology Clinics

This issue of Hematology/Oncology Clinics of North America, devoted to Colorectal Cancer, is edited by Dr. Leonard B. Saltz. Articles in this issue include: Diet and Lifestyle Influences on Colorectal Cancer; Diagnosis and Management of Germline and Somatic Mutations in Mismatch Repair-deficient Colorectal Cancer; Adjuvant Chemotherapy in Stage II, III, and Resected Stage IV Colon […]